Medipost 
Welcome,         Profile    Billing    Logout  
 5 Products   3 Diseases  5 Products   8 Trials   89 News 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neurostem (human umbilical cord blood derived allogeneic mesenchymal stem cells) / Medipost
NCT04954534: Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®

Not yet recruiting
N/A
9
RoW
human umbilical cord blood derived mesenchymal stem cells, NEUROSTEM
Samsung Medical Center, Medipost Co Ltd.
Alzheimer's Disease
01/22
06/22
Pneumostem (human umbilical cord blood-derived mesenchymal stem cells) / Medipost, Samsung Medical Center
NCT02890953: Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

Active, not recruiting
2
22
RoW
Pneumostem, Umbilical cord blood derived mesenchymal stem cells, Normal saline
Samsung Medical Center
Cell Transplantation
12/25
12/25
NCT03392467: PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants

Recruiting
2
60
RoW
PNEUMOSTEM, Placebo
Medipost Co Ltd.
Severe Bronchopulmonary Dysplasia
12/23
03/24
NCT04003857: Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

Active, not recruiting
2
60
RoW
PNEUMOSTEM®, Human umbilical cord blood-derived mesenchymal stem cells, normal saline
Medipost Co Ltd.
Bronchopulmonary Dysplasia, BPD
06/27
06/27
NCT02673788: Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

Active, not recruiting
N/A
9
RoW
observation without intervention in this follow up study
Samsung Medical Center
Intracranial Hemorrhages, Mesenchymal Stem Cells, Newborn Infant
12/22
12/23
NCT01632475: Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia

Active, not recruiting
N/A
9
RoW
Pneumostem®, Human umbilical cord blood-derived mesenchymal stem cells
Samsung Medical Center, Medipost Co Ltd.
Bronchopulmonary Dysplasia
09/25
09/26
Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
NCT01923532: A Follow-up Study of CARTISTEM® Versus Microfracture

Recruiting
3
102
RoW
Cartistem®, Microfracture
Dong-A Pharmaceutical Co., Ltd.
Cartistem®, Microfracture, Knee Articular Cartilage Injury, Cartilage Defect
05/15
 
SMUP-IA-01 / Medipost
NCT06798727: Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Active, not recruiting
2
84
RoW
SMUP-IA-01(low-dose), Human umbilical cord blood-derived mesenchymal stem cells, SMUP-IA-01(mid-dose), High Hyal Plus
Medipost Co Ltd.
Knee Osteoarthritis
03/27
11/27
NCT05182034: Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

Completed
2
94
RoW
SMUP-IA-01(low dose), SMUP allogenic cord blood-derived mesenchymal stem cell (SMUP-Cell), SMUP-IA-01(mid dose), Active Control Group Sodium chloride, Sodium chloride
Medipost Co Ltd.
Knee Osteoarthritis
10/23
10/23
NCT04339504: Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

Recruiting
1
12
RoW
SMUP-IA-01(low-dose), Human umbilical cord blood-derived mesenchymal stem cells, SMUP-IA-01(mid-dose), SMUP-IA-01(high-dose)
Medipost Co Ltd.
Knee Osteoarthritis
12/25
12/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neurostem (human umbilical cord blood derived allogeneic mesenchymal stem cells) / Medipost
NCT04954534: Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®

Not yet recruiting
N/A
9
RoW
human umbilical cord blood derived mesenchymal stem cells, NEUROSTEM
Samsung Medical Center, Medipost Co Ltd.
Alzheimer's Disease
01/22
06/22
Pneumostem (human umbilical cord blood-derived mesenchymal stem cells) / Medipost, Samsung Medical Center
NCT02890953: Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

Active, not recruiting
2
22
RoW
Pneumostem, Umbilical cord blood derived mesenchymal stem cells, Normal saline
Samsung Medical Center
Cell Transplantation
12/25
12/25
NCT03392467: PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants

Recruiting
2
60
RoW
PNEUMOSTEM, Placebo
Medipost Co Ltd.
Severe Bronchopulmonary Dysplasia
12/23
03/24
NCT04003857: Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

Active, not recruiting
2
60
RoW
PNEUMOSTEM®, Human umbilical cord blood-derived mesenchymal stem cells, normal saline
Medipost Co Ltd.
Bronchopulmonary Dysplasia, BPD
06/27
06/27
NCT02673788: Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

Active, not recruiting
N/A
9
RoW
observation without intervention in this follow up study
Samsung Medical Center
Intracranial Hemorrhages, Mesenchymal Stem Cells, Newborn Infant
12/22
12/23
NCT01632475: Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia

Active, not recruiting
N/A
9
RoW
Pneumostem®, Human umbilical cord blood-derived mesenchymal stem cells
Samsung Medical Center, Medipost Co Ltd.
Bronchopulmonary Dysplasia
09/25
09/26
Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
NCT01923532: A Follow-up Study of CARTISTEM® Versus Microfracture

Recruiting
3
102
RoW
Cartistem®, Microfracture
Dong-A Pharmaceutical Co., Ltd.
Cartistem®, Microfracture, Knee Articular Cartilage Injury, Cartilage Defect
05/15
 
SMUP-IA-01 / Medipost
NCT06798727: Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Active, not recruiting
2
84
RoW
SMUP-IA-01(low-dose), Human umbilical cord blood-derived mesenchymal stem cells, SMUP-IA-01(mid-dose), High Hyal Plus
Medipost Co Ltd.
Knee Osteoarthritis
03/27
11/27
NCT05182034: Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

Completed
2
94
RoW
SMUP-IA-01(low dose), SMUP allogenic cord blood-derived mesenchymal stem cell (SMUP-Cell), SMUP-IA-01(mid dose), Active Control Group Sodium chloride, Sodium chloride
Medipost Co Ltd.
Knee Osteoarthritis
10/23
10/23
NCT04339504: Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

Recruiting
1
12
RoW
SMUP-IA-01(low-dose), Human umbilical cord blood-derived mesenchymal stem cells, SMUP-IA-01(mid-dose), SMUP-IA-01(high-dose)
Medipost Co Ltd.
Knee Osteoarthritis
12/25
12/25

Download Options